Superior medical device to be marketed worldwide
“We’ve known for many years that one day, a better technology would come.” said Jerome Steele, CEO of the corporation. “And now, through strategic alliances, we’ve come up with that replacement ourselves.”
The EchoPulse innovation is based on the same research and theory as the original MicroVas device, but uses a different combined waveform and other parameters to achieve better results. “We’ve listened to our customers over the years,” added Steele, “and incorporated better design features as well. The EchoPulse is more powerful, lighter weight, and highly portable; and the price is about 40 percent less.”
The company’s EchoPulse device generates a comfortable electrical field that passes entirely through the limb or other treated area, inducing deep muscle contractions that effectively pump blood through the microcirculation, raise the tissue oxygen levels and drain the venous beds. It has proven highly successful in treating many forms of neuropathy and in closing stubborn, non-healing wounds, especially in diabetics.
The company will continue to support its previous technology with information and repair and plans a trade-in program for customers wishing to upgrade to the new device.
